Annual Accounts Payable
$1.81 M
-$1.05 M-36.68%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual accounts payable is $1.81 million, with the most recent change of -$1.05 million (-36.68%) on December 31, 2023.
- During the last 3 years, TRVI annual accounts payable has fallen by -$207.00 thousand (-10.27%).
- TRVI annual accounts payable is now -36.68% below its all-time high of $2.86 million, reached on December 31, 2022.
Performance
TRVI Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.61 M
+$103.00 K+6.82%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly accounts payable is $1.61 million, with the most recent change of +$103.00 thousand (+6.82%) on September 30, 2024.
- Over the past year, TRVI quarterly accounts payable has dropped by -$195.00 thousand (-10.78%).
- TRVI quarterly accounts payable is now -59.01% below its all-time high of $3.94 million, reached on June 30, 2022.
Performance
TRVI Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TRVI Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.7% | -10.8% |
3 y3 years | -10.3% | -27.7% |
5 y5 years | +200.0% | +230.1% |
TRVI Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -36.7% | at low | -59.0% | +28.5% |
5 y | 5-year | -36.7% | +13.1% | -59.0% | +101.5% |
alltime | all time | -36.7% | +236.9% | -59.0% | +230.1% |
Trevi Therapeutics Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.61 M(+6.8%) |
Jun 2024 | - | $1.51 M(-28.5%) |
Mar 2024 | - | $2.11 M(+16.7%) |
Dec 2023 | $1.81 M(-36.7%) | $1.81 M(+44.0%) |
Sep 2023 | - | $1.26 M(-7.1%) |
Jun 2023 | - | $1.35 M(-31.8%) |
Mar 2023 | - | $1.98 M(-30.6%) |
Dec 2022 | $2.86 M(+0.3%) | $2.86 M(+22.5%) |
Sep 2022 | - | $2.33 M(-40.8%) |
Jun 2022 | - | $3.94 M(+126.6%) |
Mar 2022 | - | $1.74 M(-39.0%) |
Dec 2021 | $2.85 M | $2.85 M(+27.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | $2.23 M(-36.0%) |
Jun 2021 | - | $3.49 M(+335.5%) |
Mar 2021 | - | $801.00 K(-60.3%) |
Dec 2020 | $2.02 M(+26.1%) | $2.02 M(+60.3%) |
Sep 2020 | - | $1.26 M(-60.2%) |
Jun 2020 | - | $3.16 M(+44.1%) |
Mar 2020 | - | $2.19 M(+37.1%) |
Dec 2019 | $1.60 M(+165.2%) | $1.60 M(+227.0%) |
Sep 2019 | - | $489.00 K(-81.6%) |
Jun 2019 | - | $2.66 M(+434.7%) |
Mar 2019 | - | $498.00 K(-17.4%) |
Dec 2018 | $603.00 K(+12.3%) | $603.00 K |
Dec 2017 | $537.00 K | - |
FAQ
- What is Trevi Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Trevi Therapeutics?
- What is Trevi Therapeutics annual accounts payable year-on-year change?
- What is Trevi Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly accounts payable year-on-year change?
What is Trevi Therapeutics annual accounts payable?
The current annual accounts payable of TRVI is $1.81 M
What is the all time high annual accounts payable for Trevi Therapeutics?
Trevi Therapeutics all-time high annual accounts payable is $2.86 M
What is Trevi Therapeutics annual accounts payable year-on-year change?
Over the past year, TRVI annual accounts payable has changed by -$1.05 M (-36.68%)
What is Trevi Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TRVI is $1.61 M
What is the all time high quarterly accounts payable for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly accounts payable is $3.94 M
What is Trevi Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TRVI quarterly accounts payable has changed by -$195.00 K (-10.78%)